Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Int Health ; 14(Suppl 2): ii20-ii24, 2022 09 21.
Article in English | MEDLINE | ID: covidwho-2318774

ABSTRACT

Innovation plays a critical role in progress towards achievement of the World Health Organization's road map for neglected tropical diseases 2021-2030. As disease prevalence decreases, the cost to identify and treat remaining cases goes up. Additionally, as programmes move to the surveillance phase, diagnostic tests need to be highly sensitive and affordable. Until the early end to the Ascend West and Central Africa programme, the Ascend Learning and Innovation Fund supported five projects from 2019 to 2021. Designed for innovation, the fund encompassed a range of activities, including operational research, product development and social behavioural change. This flexibility allowed innovation to bridge the gap between strategic policy and practical implementation, piloting and proving business models to respond to information found through Ascend.


Subject(s)
Neglected Diseases , Policy , Humans , Neglected Diseases/prevention & control
2.
Int Health ; 14(Suppl 2): ii70-ii73, 2022 09 21.
Article in English | MEDLINE | ID: covidwho-2315355

ABSTRACT

Living in an increasingly interconnected world, epidemics and pandemics are increasingly likely to be a vista for the future. This, coupled with the likely devastating effects of climate change, means that humanitarian crises are likely to increase. Now, more than ever before, is the time to scale up investment in prevention and preparedness strategies, and to review our current approaches to delivering health services, including those that address neglected tropical diseases. The Ascend West and Central Africa programme has illustrated the importance of innovation, multisector partnerships, resilience and the opportunity for change.


Subject(s)
Pandemics , Tropical Medicine , Humans , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Pandemics/prevention & control
4.
Science ; 379(6633): 627, 2023 02 17.
Article in English | MEDLINE | ID: covidwho-2274414
5.
Comp Immunol Microbiol Infect Dis ; 90-91: 101888, 2022.
Article in English | MEDLINE | ID: covidwho-2252073

ABSTRACT

Scrub typhus is an under diagnosed re-emerging vector borne disease caused by an intracellular gram negative bacteria, Orientia. The disease is commonly prevalent in rural and hilly areas of Tsutsugumashi triangle. The diagnosis of the disease is very challenging due to similarity of its early symptoms with other febrile illnesses, like dengue and COVID 19, as well as non-availability of rapid, reliable and cost-effective methods. Moreover, the diverse clinical presentation in severe cases make it significant health problem. The occupational and behavioral risks responsible for the transmission lead to urgent need of vaccine development against the disease. The complete knowledge about its pathogenesis and the interaction with host's immune cells may help the scientists in developing the appropriate diagnostic methods as well as the vaccines.


Subject(s)
COVID-19 , Neglected Diseases , Orientia tsutsugamushi , Scrub Typhus , Vaccines , Animals , Scrub Typhus/diagnosis , Scrub Typhus/epidemiology , Scrub Typhus/veterinary , COVID-19/veterinary , Neglected Diseases/diagnosis , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Neglected Diseases/veterinary
6.
Lancet Glob Health ; 10(11): e1600-e1611, 2022 11.
Article in English | MEDLINE | ID: covidwho-2069829

ABSTRACT

BACKGROUND: In line with movement restrictions and physical distancing essential for the control of the COVID-19 pandemic, WHO recommended postponement of all neglected tropical disease (NTD) control activities that involve community-based surveys, active case finding, and mass drug administration in April, 2020. Following revised guidance later in 2020, and after interruptions to NTD programmes of varying lengths, NTD programmes gradually restarted in the context of an ongoing pandemic. However, ongoing challenges and service gaps have been reported. This study aimed to evaluate the potential effect of the programmatic interruptions and strategies to mitigate this effect. METHODS: For seven NTDs, namely soil-transmitted helminths, schistosomiasis, lymphatic filariasis, onchocerciasis, trachoma, visceral leishmaniasis, and human African trypanosomiasis, we used mathematical transmission models to simulate the effect of programme interruptions on the dynamics of each of these diseases in different endemic settings. We also explored the potential benefit of implementing mitigation strategies, primarily in terms of minimising the delays to control targets. FINDINGS: We show that the effect of the COVID-19-induced interruption in terms of delay to achieving elimination goals might in some cases be much longer than the duration of the interruption. For schistosomiasis, onchocerciasis, trachoma, and visceral leishmaniasis, a mean delay of 2-3 years for a 1-year interruption is predicted in areas of highest prevalence. We also show that these delays can largely be mitigated by measures such as additional mass drug administration or enhanced case-finding. INTERPRETATION: The COVID-19 pandemic has brought infectious disease control to the forefront of global consciousness. It is essential that the NTDs, so long neglected in terms of research and financial support, are not overlooked, and remain a priority in health service planning and funding. FUNDING: Bill & Melinda Gates Foundation, Medical Research Council, and the UK Foreign, Commonwealth & Development Office.


Subject(s)
COVID-19 , Leishmaniasis, Visceral , Onchocerciasis , Schistosomiasis , Trachoma , Tropical Medicine , COVID-19/epidemiology , COVID-19/prevention & control , Humans , Leishmaniasis, Visceral/epidemiology , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Onchocerciasis/prevention & control , Pandemics , Schistosomiasis/epidemiology , Schistosomiasis/prevention & control , Soil , Trachoma/epidemiology
8.
Int Health ; 14(Suppl 2): ii7-ii19, 2022 09 21.
Article in English | MEDLINE | ID: covidwho-2037461

ABSTRACT

BACKGROUND: The neglected tropical disease (NTD) sector is adapting to the uncertain circumstances of coronavirus disease 2019 (COVID-19). The development of the Risk Assessment and Mitigation Action (RAMA) tool was driven by partners of the programme Accelerating the Sustainable Control and Elimination of NTDs (hereafter called Ascend) to enable countries to recommence NTD activities following the World Health Organization advisories of April and July 2020. This article explores the advantages of the RAMA process for NTD delivery. METHODS: The analysis used interview transcripts with NTD practitioners in Cote d'Ivoire, Guinea, Liberia and Nigeria and results from the monitoring of compliance with COVID-19 mitigation measures in Nigeria. RESULTS: Three themes emerged from the results: adaptability and innovation, collaboration and government ownership and preparedness. CONCLUSIONS: The advantages of the RAMA tool suggest its importance in mitigating the transmission of COVID-19 during NTD delivery. There is the potential for the tool to be adapted for use throughout future pandemics.


Subject(s)
COVID-19 , Tropical Medicine , Humans , Neglected Diseases/prevention & control , Pandemics/prevention & control , Risk Assessment
10.
Comb Chem High Throughput Screen ; 25(14): 2387-2390, 2022.
Article in English | MEDLINE | ID: covidwho-1834105

ABSTRACT

Neglected Tropical Diseases (NTDs) are a group of twenty (20) chronic, communicable, infectious diseases endemic to the tropics and sub-tropics climate countries, which are intimately associated with poverty, poor sanitation, limited clean water, and healthcare delivery; and dwellers live in proximity to pathogens and diseases vectors. The pathogens are protozoans, bacteria, helminths, fungi, and viruses. NTDs currently affect about one billion people globally, out of which 500 million are Africans living in rural settlements with low political voice and support. In recent years, NTDs have received little research recognition, development, and funding because more research efforts by global health stakeholders are focused on recognized diseases like cancers, hepatitis, tuberculosis, Acquired Immune-Deficiency Syndrome (AIDS), and malaria that affects most developed countries. The emergence of the viral novel COVID-19 will exacerbate the burden of NTDs on disadvantaged communities as global health efforts are again focused on COVID-19 clearance in terms of research and development to find a drug/vaccine amidst other investigations on recognized infections. This development can result in high death tolls due to NTDs if control measures are not prioritized now. This perspective addresses the need for NTDs control amidst COVID-19 clearance efforts to mitigate another viral health crisis in Africa.


Subject(s)
COVID-19 , Tuberculosis , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Pandemics/prevention & control , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Global Health
11.
Int Health ; 14(1): 111-112, 2022 01 19.
Article in English | MEDLINE | ID: covidwho-1795249

ABSTRACT

Attention is now beginning to focus on implementation of the new WHO NTD Roadmap (2021-2030), which presents single disease alliances and coalitions with an opportunity to consider novel ways to integrate and adapt control and elimination programmes to meet the new goals. This discussion piece links the parasitic worm diseases, caused by soil-transmitted helminths and schistosomes, highlighting that neglected tropical disease-control programmes could potentially benefit from greater cohesion and innovation, especially when increasing efforts to achieve elimination goals.


Subject(s)
Helminthiasis , Helminths , Schistosomiasis , Tropical Medicine , Animals , Helminthiasis/prevention & control , Humans , Neglected Diseases/prevention & control , Schistosomiasis/prevention & control , Soil/parasitology
12.
PLoS Negl Trop Dis ; 15(12): e0009904, 2021 12.
Article in English | MEDLINE | ID: covidwho-1724768

ABSTRACT

Since its early spread in early 2020, the disease caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Disease 2019 (COVID-19) has caused mass disruptions to health services. These have included interruptions to programs that aimed to prevent, control, and eliminate neglected tropical diseases (NTDs). In March 2020, the World Health Organization (WHO) released interim guidelines recommending the temporary cessation of mass drug administration (MDA), community-based surveys, and case detection, while encouraging continuation of morbidity management and vector control where possible. Over the course of the following months, national programs and implementing partners contributed to COVID-19 response efforts, while also beginning to plan for resumption of NTD control activities. To understand the challenges, opportunities, and recommendations for maximizing continuity of disease control during public health emergencies, we sought perspectives from Nigeria and Guinea on the process of restarting NTD control efforts during the COVID-19 pandemic. Through semistructured interviews with individuals involved with NTD control at the local and national levels, we identified key themes and common perspectives between the 2 countries, as well as observations that were specific to each. Overall, interviewees stressed the challenges posed by COVID-19 interruptions, particularly with respect to delays to activities and related knock-on impacts, such as drug expiry and prolonged elimination timelines, as well as concerns related to funding. However, respondents in both countries also highlighted the benefits of a formal risk assessment approach, particularly in terms of encouraging information sharing and increasing coordination and advocacy. Recommendations included ensuring greater availability of historical data to allow better monitoring of how future emergencies affect NTD control progress; continuing to use risk assessment approaches in the future; and identifying mechanisms for sharing lessons learned and innovations between countries as a means of advancing postpandemic health systems and disease control capacity strengthening.


Subject(s)
COVID-19 , Communicable Disease Control/organization & administration , Neglected Diseases/prevention & control , Communicable Disease Control/economics , Government Programs/economics , Government Programs/organization & administration , Guinea , Humans , Mass Drug Administration , Nigeria , SARS-CoV-2 , Tropical Medicine/methods
13.
PLoS Negl Trop Dis ; 15(11): e0009523, 2021 11.
Article in English | MEDLINE | ID: covidwho-1593078

ABSTRACT

BACKGROUND: Billions of doses of medicines are donated for mass drug administrations in support of the World Health Organization's "Roadmap to Implementation," which aims to control, eliminate, and eradicate Neglected Tropical Diseases (NTDs). The supply chain to deliver these medicines is complex, with fragmented data systems and limited visibility on performance. This study empirically evaluates the impact of an online supply chain performance measurement system, "NTDeliver," providing understanding of the value of information sharing towards the success of global health programs. METHODS: Retrospective secondary data were extracted from NTDeliver, which included 1,484 shipments for four critical medicines ordered by over 100 countries between February 28, 2006 and December 31, 2018. We applied statistical regression models to analyze the impact on key performance metrics, comparing data before and after the system was implemented. FINDINGS: The results suggest information sharing has a positive association with improvement for two key performance indicators: purchase order timeliness (ß = 0.941, p = 0.003) and-most importantly-delivery timeliness (ß = 0.828, p = 0.027). There is a positive association with improvement for three variables when the data are publicly shared: shipment timeliness (ß = 2.57, p = 0.001), arrival timeliness (ß = 2.88, p = 0.003), and delivery timeliness (ß = 2.82, p = 0.011). CONCLUSIONS: Our findings suggest that information sharing between the NTD program partners via the NTDeliver system has a positive association with supply chain performance improvements, especially when data are shared publicly. Given the large volume of medicine and the significant number of people requiring these medicines, information sharing has the potential to provide improvements to global health programs affecting the health of tens to hundreds of millions of people.


Subject(s)
Neglected Diseases/prevention & control , Tropical Medicine , Chemoprevention , Humans , Information Dissemination , Retrospective Studies
14.
Trans R Soc Trop Med Hyg ; 116(5): 446-453, 2022 05 02.
Article in English | MEDLINE | ID: covidwho-1584040

ABSTRACT

The São Tomé e Príncipe government is committed to achieving neglected tropical disease (NTD) control and elimination as a public health problem by 2025. In 2014, the Ministry of Health led a national survey to determine the prevalence of soil-transmitted helminths (STHs) and schistosomiasis across the country. Following this survey, a preventive chemotherapy (PC) campaign with mebendazole and praziquantel reached 31 501 school-age children in 2015. A follow-up 2017 survey to determine the impact of the intervention showed success in controlling schistosomiasis, as no infections were found, but limited impact on STHs, with prevalence similar to pretreatment levels. The survey also investigated the prevalence of a third NTD, lymphatic filariasis (LF), which was found to be endemic in the country. Since then the Ministry of Health has developed the Strategic Plan for the Fight Against Neglected Tropical Diseases 2019-2025 and identified gaps to be addressed. This narrative review systematises the existing literature reporting on the epidemiology of NTDs for which there are PC programs in São Tomé e Príncipe. PubMed was searched for relevant papers that measured the prevalence of LF, schistosomiasis and STHs. Additionally, data provided by the Ministry of Health surveys were analysed. Finally, we discuss current NTD control, including the impact of the coronavirus disease 2019 pandemic and identify priorities for program strengthening and operational research.


Subject(s)
COVID-19 , Elephantiasis, Filarial , Helminthiasis , Helminths , Schistosomiasis , Tropical Medicine , Animals , Child , Elephantiasis, Filarial/drug therapy , Elephantiasis, Filarial/epidemiology , Elephantiasis, Filarial/prevention & control , Helminthiasis/drug therapy , Helminthiasis/epidemiology , Helminthiasis/prevention & control , Humans , Neglected Diseases/drug therapy , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Schistosomiasis/drug therapy , Schistosomiasis/epidemiology , Schistosomiasis/prevention & control , Soil/parasitology
15.
Adv Parasitol ; 114: 1-26, 2021.
Article in English | MEDLINE | ID: covidwho-1458847

ABSTRACT

Human parasitic infections-including malaria, and many neglected tropical diseases (NTDs)-have long represented a Gordian knot in global public health: ancient, persistent, and exceedingly difficult to control. With the coronavirus disease (Covid-19) pandemic substantially interrupting control programmes worldwide, there are now mounting fears that decades of progress in controlling global parasitic infections will be undone. With Covid-19 moreover exposing deep vulnerabilities in the global health system, the current moment presents a watershed opportunity to plan future efforts to reduce the global morbidity and mortality associated with human parasitic infections. In this chapter, we first provide a brief epidemiologic overview of the progress that has been made towards the control of parasitic diseases between 1990 and 2019, contrasting these fragile gains with the anticipated losses as a result of Covid-19. We then argue that the complementary aspirations of the United Nations Sustainable Development Goals (SDGs) and the World Health Organization (WHO)'s 2030 targets for parasitic disease control may be achieved by aligning programme objectives within the One Health paradigm, recognizing the interdependence between humans, animals, and the environment. In so doing, we note that while the WHO remains the preeminent international institution to address some of these transdisciplinary concerns, its underlying challenges with funding, authority, and capacity are likely to reverberate if left unaddressed. To this end, we conclude by reimagining how models of multisectoral global health governance-combining the WHO's normative and technical leadership with greater support in allied policy-making areas-can help sustain future malaria and NTD elimination efforts.


Subject(s)
COVID-19 , One Health , Parasitic Diseases , Tropical Medicine , Animals , Global Health , Humans , Neglected Diseases/epidemiology , Neglected Diseases/prevention & control , Parasitic Diseases/epidemiology , Parasitic Diseases/prevention & control , SARS-CoV-2
16.
PLoS Negl Trop Dis ; 15(8): e0009595, 2021 08.
Article in English | MEDLINE | ID: covidwho-1416859

ABSTRACT

BACKGROUND: Sustainability within neglected tropical disease (NTD) programs is a complex and challenging issue. The need for a shared understanding about what sustainability means for NTD programs is more important than ever as stakeholders are currently realigning for the next decade of NTD programming with the launch of WHO's new NTD roadmap for 2012-2030. The aim of this paper is to assess different perspectives to generate a working definition of sustainability for NTD programs. METHODOLOGY/PRINCIPAL FINDINGS: This study surveyed affiliates of the NTD NGO Network (NNN) about their definitions of sustainability and then analyzed the data using an inductive and deductive process. The research team drafted a sustainability statement based on the survey findings and then solicited and incorporated feedback on the statement from a diverse group of expert reviewers. The final statement includes a working definition of sustainability for NTD programs that highlights three key essential components to sustainability: domestic commitment, responsive resource mobilization, and accountability. CONCLUSIONS/SIGNIFICANCE: This research resulted in a sustainability statement, based on a survey and extensive consultation with stakeholders, that represents a starting point for shared understanding around the concept of sustainability for NTD programs. Future collaborative work should build off this definition and seek to incorporate indicators for sustainability into programmatic decision-making.


Subject(s)
Disease Eradication/methods , Disease Eradication/organization & administration , Neglected Diseases/prevention & control , Program Evaluation , Global Health , Humans , Social Responsibility , World Health Organization
17.
PLoS Negl Trop Dis ; 15(8): e0009626, 2021 08.
Article in English | MEDLINE | ID: covidwho-1365416

ABSTRACT

"Fit-for-purpose" diagnostic tests have emerged as a prerequisite to achieving global targets for the prevention, control, elimination, and eradication of neglected tropical diseases (NTDs), as highlighted by the World Health Organization's (WHO) new roadmap. There is an urgent need for the development of new tools for those diseases for which no diagnostics currently exist and for improvement of existing diagnostics for the remaining diseases. Yet, efforts to achieve this, and other crosscutting ambitions, are fragmented, and the burden of these 20 debilitating diseases immense. Compounded by the Coronavirus Disease 2019 (COVID-19) pandemic, programmatic interruptions, systemic weaknesses, limited investment, and poor commercial viability undermine global efforts-with a lack of coordination between partners, leading to the duplication and potential waste of scant resources. Recognizing the pivotal role of diagnostic testing and the ambition of WHO, to move forward, we must create an ecosystem that prioritizes country-level action, collaboration, creativity, and commitment to new levels of visibility. Only then can we start to accelerate progress and make new gains that move the world closer to the end of NTDs.


Subject(s)
Neglected Diseases/prevention & control , Tropical Medicine , COVID-19/diagnosis , Disease Eradication , Humans , Neglected Diseases/diagnosis , SARS-CoV-2 , World Health Organization
18.
PLoS Negl Trop Dis ; 14(9): e0007956, 2020 09.
Article in English | MEDLINE | ID: covidwho-1339406

ABSTRACT

In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.


Subject(s)
Biomedical Technology/economics , Neglected Diseases/prevention & control , Biomedical Technology/organization & administration , Biomedical Technology/trends , Financial Management , Global Health/economics , Humans , Neglected Diseases/economics , Neglected Diseases/epidemiology , Republic of Korea/epidemiology
19.
Trans R Soc Trop Med Hyg ; 115(2): 182-184, 2021 01 28.
Article in English | MEDLINE | ID: covidwho-1307557

ABSTRACT

The forthcoming World Health Organization road map for neglected tropical diseases (NTDs) 2021-2030 recognises the complexity surrounding control and elimination of these 20 diseases of poverty. It emphasises the need for a paradigm shift from disease-specific interventions to holistic cross-cutting approaches coordinating with adjacent disciplines. The One Health approach exemplifies this shift, extending beyond a conventional model of zoonotic disease control to consider the interactions of human and animal health systems within their shared environment and the wider social and economic context. This approach can also promote sustainability and resilience within these systems. To achieve the global ambition on NTD elimination and control, political will, along with contextualised innovative scientific strategies, is required.


Subject(s)
One Health , Tropical Medicine , Animals , Global Health , Humans , Neglected Diseases/prevention & control , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL